Equity Overview
Price & Market Data
Price: $0.76
Daily Change: +$0.0914 / 12.02%
Range: $0.64 - $0.921
Market Cap: $4,622,321
Volume: 421,800
Performance Metrics
1 Week: 17.44%
1 Month: -7.45%
3 Months: -39.23%
6 Months: -45.89%
1 Year: -65.50%
YTD: -20.19%
Details
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.